Repligen (RGEN) Change in Account Payables (2010 - 2026)
Repligen's (RGEN) quarterly Change in Account Payables came in at $194000.0 in Q2 2026, up 112.25% year-over-year from $91402.7 in Q2 2025, and down 96.72% quarter-over-quarter from $5.9 million in Q1 2026.
Analysis
Repligen (RGEN) Change in Account Payables (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Change in Account Payables for 17 consecutive years, with $194000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Account Payables rose 112.25% year-over-year to $194000.0 in Q2 2026; TTM through Jun 2026 was $10.2 million, a 233.08% increase from a year earlier, with the FY2025 full-year figure at -$4.1 million, down 132.18% from the prior year.
- Change in Account Payables was $194000.0 for Q2 2026 at Repligen, down from $5.9 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $11.1 million in Q4 2024 and troughed at -$16.4 million in Q3 2022.
- A 5-year average of -$174444.4 and a median of $213500.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables sank 2626.27% in 2022 and jumped 1270.82% in 2025, its largest moves.
- Over 5 years, Change in Account Payables stood at $1.9 million in 2022, then plunged by 161.44% to -$1.2 million in 2023, then soared by 1039.02% to $11.1 million in 2024, then sank by 91.61% to $933000.0 in 2025, then slumped by 79.21% to $194000.0 in 2026.
- The last three Change in Account Payables figures came in at $194000.0 (Q2 2026), $5.9 million (Q1 2026), and $933000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -13.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 10.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -4.32 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 194,000.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.29 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 194,000.00 |
| Mar 31, 2026 | 5.92 Mn |
| Dec 31, 2025 | 933,000.00 |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -6.69 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | -645,000.00 |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -4.75 Mn |
| Jun 30, 2023 | -2.68 Mn |
| Mar 31, 2023 | -1.19 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Sep 30, 2022 | -16.45 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 10.56 Mn |
| Sep 30, 2021 | 651,000.00 |